Article

Investigation of antifibrotic properties of lithium as a potential treatment agent for idiopathic pulmonary fibrosis and comparing its antifibrotic activity with standard of care drugs for IPF

2024-08-27

Abstract excerpt

<title>Abstract</title> <p>Background In this study, we examined in a proprietary in vitro system the antifibrotic properties of lithium and its modulating effect on telomere maintenance and telomerase activity. Lithium effects were compared with FDA-approved drugs for the treatment of Idiopathic pulmonary fibrosis. Methods Lithium in three different concentrations, Nintedanib and Pirfenidone were tested in InM...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5cac1463-09cf-5842-a34e-1c783449aff4
DOI: 10.21203/rs.3.rs-4777803/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Investigation of antifibrotic properties of lithium as a potential treatment agent for idiopathic pulmonary fibrosis and comparing its antifibrotic activity with standard of care drugs for IPFDOI 10.21203/rs.3.rs-4777803/v1Read

Current and Future Treatment Landscape for Idiopathic Pulmonary Fibrosis.Semantic proximity Read

An update on emerging drugs for the treatment of idiopathic pulmonary fibrosis.Semantic proximity Read

Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases.Semantic proximity Read

A noble TGFβ biogenesis inhibitor exhibits both potent anti-fibrotic and anti-inflammatory capabilitiesSemantic proximity Read

Inhibition of fibrosis with multi-agent therapy in pulmonary fibrosis: Results of a drug library screeningSemantic proximity Read

Fibrotic human lung extracellular matrix as a disease-specific substrate for 3D <i>in-vitro</i> models of pulmonary fibrosisSemantic proximity Read

Fibroblast-matrix interplay: Nintedanib and pirfenidone modulate the effect of IPF fibroblast-conditioned matrix on normal fibroblast phenotype.Semantic proximity Read

Regulation of idiopathic pulmonary fibrosis: a cross-talk between TGF-β signaling and MicroRNAsSemantic proximity Read

Idiopathic Pulmonary Fibrosis: Molecular Endotypes of Fibrosis Stratifying Existing and Emerging Therapies.Semantic proximity Read

[How i treat a patient with idiopathic pulmonary fibrosis].Semantic proximity Read

Nintedanib and Pirfenidone Affect Growth and Differentiation of Human Alveolar Type 2 CellsSemantic proximity Read

Combined therapy with pirfenidone and nintedanib counteracts fibrotic silicosis in miceSemantic proximity Read